<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap-new?view=xsl&amp;format=xsl&amp;layout=news&amp;id=2"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/23627-lipodistrofia-riconoscere-le-forme-meno-evidenti-per-evitare-diagnosi-mancate]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-11T23:02:55Z</news:publication_date><news:title><![CDATA[Lipodistrofia: riconoscere le forme meno evidenti per evitare diagnosi mancate]]></news:title><news:keywords><![CDATA[lipodistrofia]]></news:keywords></news:news></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/23619-malattia-di-huntington-unindagine-europea-da-voce-a-pazienti-e-famiglie]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-10T23:01:16Z</news:publication_date><news:title><![CDATA[Malattia di Huntington, un'indagine europea dà voce a pazienti e famiglie]]></news:title><news:keywords><![CDATA[Malattia di Huntington]]></news:keywords></news:news></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/23630-leucemia-linfoblastica-acuta-ph-nuove-prospettive-terapeutiche-dalla-ricerca-italiana]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-11T23:05:01Z</news:publication_date><news:title><![CDATA[Leucemia linfoblastica acuta Ph+, nuove prospettive terapeutiche dalla ricerca italiana]]></news:title><news:keywords><![CDATA[leucemia linfoblastica acuta]]></news:keywords></news:news></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/23624-tecnologie-assistive-per-ledf-ancora-troppi-gli-ostacoli-allaccesso-in-ue]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-10T23:01:22Z</news:publication_date><news:title><![CDATA[Tecnologie assistive, per l’EDF ancora troppi gli ostacoli all’accesso in UE]]></news:title><news:keywords><![CDATA[disabilità]]></news:keywords></news:news></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/23625-fibrodisplasia-ossificante-progressiva-zilurgisertib-riduce-le-formazioni-ossee-patologiche]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-10T23:03:49Z</news:publication_date><news:title><![CDATA[Fibrodisplasia ossificante progressiva: zilurgisertib riduce le formazioni ossee patologiche]]></news:title><news:keywords><![CDATA[Fibrodisplasia ossificante progressiva]]></news:keywords></news:news></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/23626-carbon-x-lintelligenza-artificiale-che-puo-aiutare-a-diagnosticare-le-malattie-genetiche-rare]]></loc><news:news><news:publication><news:name/><news:language>it-it</news:language></news:publication><news:publication_date>2026-11-11T23:01:30Z</news:publication_date><news:title><![CDATA[Carbon-X, l'intelligenza artificiale che può aiutare a diagnosticare le malattie genetiche rare]]></news:title><news:keywords><![CDATA[intelligenza artificiale]]></news:keywords></news:news></url></urlset>